- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/06 - Oxygen atoms
Patent holdings for IPC class C07D 451/06
Total number of patents in this class: 243
10-year publication summary
|
17
|
11
|
17
|
13
|
21
|
13
|
19
|
11
|
7
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3168 |
7 |
| Neurosearch A/S | 146 |
7 |
| Skyhawk Therapeutics, Inc. | 151 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
6 |
| Merck Patent GmbH | 5728 |
5 |
| Fedora Pharmaceuticals Inc. | 16 |
5 |
| Rigel Pharmaceuticals, Inc. | 507 |
5 |
| The University of Edinburgh | 27 |
5 |
| Xenon Pharmaceuticals Inc. | 197 |
5 |
| Actinogen Medical Limited | 14 |
5 |
| Merck Sharp & Dohme LLC | 3734 |
5 |
| Nippon Soda Co., Ltd. | 884 |
4 |
| Schering Corporation | 350 |
4 |
| Odyssey Therapeutics, Inc. | 36 |
4 |
| Bristol-myers Squibb Company | 4742 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Massachusetts Institute of Technology | 10251 |
3 |
| Agency for Science, Technology and Research | 3733 |
3 |
| ACADIA Pharmaceuticals Inc. | 194 |
3 |
| BioMarin Pharmaceutical Inc. | 400 |
3 |
| Other owners | 151 |